Korsana Biosciences, Inc.
KRSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001755237
No open-market purchases or sales by Korsana Biosciences, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding KRSA, Q2 2026
No superinvestor reported holding KRSA at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Korsana Biosciences, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 25, 2024 (view filing)4:05 PM ET | Nov 21 | 4 days | Slate Path Capital LP and 1 other10% Owner | SSaleCommon Stock, no par value | −357.9K | $1.55 | −$555.1K | −100.0%0 after | |
| Aug 11, 2023 (view filing) | Aug 9 | 2 days | McGuire TerranceDirector | SSale | −8 | $3.40 | −$27.2 | −100.0%0 after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Korsana Biosciences, Inc. at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding KRSA in 13F filings for Q2 2026.